comparemela.com

University Of St Andrews School Medicine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Delays in dealing with complaints against drug companies are growing, BMJ finds

A major backlog has developed in handling complaints over drug companies’ marketing practices in the UK. Hristio Boytchev , Shai Mulinari , and Piotr Ozieranski report Processing times for complaints against drug companies suspected of having breached the UK industry’s code of practice governing the promotion of pharmaceuticals have more than tripled in nearly two decades, an investigation by The BMJ has found. Delays mean that any problematic practices highlighted in complaints can continue for an average of eight months and in many cases for more than a year. To tackle the backlog, the Association of the British Pharmaceutical Industry (ABPI) has now raised the fees charged to companies in relation to these complaints by more than 40%. Complaints against ABPI members and non-members that have ratified the ABPI’s code of practice are dealt with by the arm’s length body the Prescription Medicines Code of Practice Authority (PMCPA). In the most severe cases the ABPI can suspe

The people prescribed golf for their health

Revealed: maker of Wegovy skinny jab is funding NHS weight-loss services | Pharmaceuticals industry

Socioeconomic inequities and structural racism are neglected pieces of SARS-CoV-2 transmission networks

Socioeconomic inequities and structural racism are neglected pieces of SARS-CoV-2 transmission networks A recent perspective article published in the prestigious journal Science highlights how the use of network-driven strategies for adequately informing rapidly emergent epidemic responses is not only evidence-based but also an equitable way forward for the current coronavirus disease (COVID-19) pandemic and future respiratory pandemics. Image Credit: hedgehog94 / Shutterstock and American Association for the Advancement of Science Even though each contact carries a certain risk of acquiring an infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), real-world social networks in the context of an ongoing COVID-19 pandemic should be viewed as rather complex and extremely heterogeneous.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.